tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Compare Inhibikase Therapeutics (IKT) vs. Competitors

376 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Inhibikase Therapeutics
$1.70
$224.46M
-4.18
-8.60%
5 Buy
0 Hold
0 Sell
Strong Buy
Atossa Therapeutics
$4.94
$42.54M
-2.19
-44.15%
3 Buy
0 Hold
0 Sell
Strong Buy
Anixa Biosciences
$3.16
$90.19M
-9.85
1.13%
2 Buy
0 Hold
0 Sell
Moderate Buy
Spero Therapeutics
$2.59
$154.57M
15.23
362.74%
Surrozen
$28.20
$323.93M
-0.70
207.56%
4 Buy
0 Hold
0 Sell
Strong Buy
TScan Therapeutics
$1.05
$59.75M
-1.00
-7.08%
5 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IKT
Inhibikase Therapeutics
1.70
-0.30
-15.00%
ATOS
Atossa Therapeutics
4.94
-4.58
-48.09%
ANIX
Anixa Biosciences
2.69
0.04
1.51%
SPRO
Spero Therapeutics
2.67
1.97
280.88%
SRZN
Surrozen
28.20
18.71
197.15%
TCRX
TScan Therapeutics
1.05
-0.19
-15.32%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts